We just received data on a new analyst forecast for $CVRX. Sarah James from Cantor Fitzgerald set a price target of 2.0 for CVRX.
To track analyst ratings and price targets for $CVRX, check out Quiver Quantitative's $CVRX forecast page.
Should you buy $CVRX?
Some analysts are better than others. To view the past performance of Cantor Fitzgerald, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$CVRX Price Targets
Multiple analysts have issued price targets for $CVRX recently. We have seen 3 analysts offer price targets for $CVRX in the last 6 months, with a median target of $2.0.
Here are some recent targets:
- Sarah James from Cantor Fitzgerald set a target price of $2.0 on 11/13/2026
- Frank Takkinen from Lake Street set a target price of $1.5 on 11/06/2026
- William Plovanic from Canaccord Genuity set a target price of $2.0 on 11/06/2026
$CVRX Insider Trading Activity
$CVRX insiders have traded $CVRX stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CVRX stock by insiders over the last 6 months:
- BRENT BINKOWSKI (CHIEF OPERATING OFFICER) has made 1 purchase buying 26,223 shares for an estimated $76,432 and 1 sale selling 1,309 shares for an estimated $3,338.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CVRX Hedge Fund Activity
We have seen 42 institutional investors add shares of $CVRX stock to their portfolio, and 55 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BALYASNY ASSET MANAGEMENT L.P. removed 630,812 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $3,242,373
- ROYAL BANK OF CANADA added 526,262 shares (+74.4%) to their portfolio in Q2 2026, for an estimated $2,704,986
- PARKMAN HEALTHCARE PARTNERS LLC removed 429,507 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $2,207,665
- PFM HEALTH SCIENCES, LP added 369,572 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,899,600
- SILVERCREST ASSET MANAGEMENT GROUP LLC added 306,088 shares (+53.5%) to their portfolio in Q2 2026, for an estimated $1,573,292
- FIRST EAGLE INVESTMENT MANAGEMENT, LLC added 220,758 shares (+inf%) to their portfolio in Q3 2026, for an estimated $386,326
- RENAISSANCE TECHNOLOGIES LLC added 205,400 shares (+89.3%) to their portfolio in Q3 2026, for an estimated $359,450
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.